Welsis Stock Price, News & Analysis
Company Description
Welsis (OTC Link: WLSS) is a publicly traded health information services company in the Healthcare sector. The company has a market capitalization of $6.9M.
WLSS stock has declined 28.9% over the past year. Shares last traded at $2.49.
On a trailing twelve-month basis, Welsis reported revenue of $0 and diluted earnings per share of $-0.02.
This page provides a comprehensive overview of WLSS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Welsis (WLSS) stock last traded at $2.49. Over the past 12 months, the stock has lost 28.9%. At a market capitalization of $6.9M, WLSS is classified as a micro-cap stock with approximately 2.8M shares outstanding.
WLSS Rankings
Latest News
SEC Filings
Welsis has filed 4 recent SEC filings, including 1 Form NT 10-Q, 1 Form 10-Q, 1 Form 10-K, 1 Form NT 10-K. The most recent filing was submitted on May 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all WLSS SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.02. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
WLSS Company Profile & Sector Positioning
Welsis (WLSS) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.